BioSpace News Archive

A new, large-scale study of more than 5 million mammograms found that annual mammography screening beginning at age 30 may benefit women with at least one of three specific risk factors: dense breasts, a personal history of breast cancer or a family history of breast cancer.

kathy ireland® Worldwide (kiWW®) and Molecular Testing Labs® (MOLECULAR) are collaborating to make at-home HIV testing available for $25 in support of World AIDS Day 2018. From December 1st through December 7th, individuals can purchase self-collect HIV testing kits for a flat fee of $25.00 directly at www.myhometests.com.

DexCom, Inc. announced today the pricing of its offering of $750.0 million aggregate principal amount of 0.75% Convertible Senior Notes due 2023 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended

Grand Opening Event debuting Artificial Intelligence-powered, virtual medical clinics inside Phoenix-area Safeway stores. Mayor Mark Mitchell to host ribbon cutting and make remarks.

Navidea Biopharmaceuticals, Inc. today announced that its Chief Executive Officer, Jed Latkin, will present a corporate overview of the Company at the 11th Annual LD Micro Event, being held December 4-6, 2018 in Bel-Air, California.

Symbility Solutions Inc. today announced financial results for the third quarter ending September 30, 2018.

Acceleron Pharma Inc. today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to ACE-083, the Company’s locally-acting “Myostatin+” muscle agent, for the treatment of patients with Charcot-Marie-Tooth disease (CMT).

HOOKIPA will perform the validation experiments and be granted exclusive rights to the development, manufacturing and commercialization of products arising from the collaboration.

Identifying novel PDAC candidates using a computational approach

The National Pharmaceutical Council (NPC) today announced that Richard H. Bagger, Executive Vice President, Corporate Affairs and Market Access, Celgene Corporation, has been elected Chair of NPC’s Board of Directors for 2018-2019.